AR Inhibitors Identified by High-Throughput Microscopy Detection of Conformational Change and Subcellular Localization
Authors:
- 23 February 2009
- journal article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 4 (3) , 199-208
Abstract
Signaling via the androgen receptor (AR) plays an important role in human health and disease. All currently available anti-androgens prevent ligand access to the receptor, either by limiting androgen synthesis or by competitive antagonism at the ligand binding domain. It is unknown to what extent various steps of receptor activation may be separable and distinctly targeted by inhibitors. We have previously described the use of fluorescent protein fusions to AR to monitor its subcellular distribution and ligand-induced conformational change by fluorescence resonance energy transfer (FRET). We have now used a microscopy-based screen to identify inhibitors that prevent AR conformational change or nuclear accumulation after ligand activation. Hits were secondarily selected on the basis of their ability to inhibit AR transcription at a PSA-luciferase promoter and were tested for effects on (3)H-DHT binding to AR in cells. We find a strong correlation between compounds that block DHT binding and those that inhibit nuclear accumulation. These compounds are structurally distinct from known antagonists. Additional compounds blocked AR conformational change but did not affect DHT binding or nuclear localization of AR. One compound increased ligand-induced FRET yet functioned as a potent inhibitor. These results suggest that multiple inhibitory conformations of AR are possible and can be induced by diverse mechanisms. The lead compounds described here may be candidates for the development of novel antiandrogens and may help identify new therapeutic targets.Keywords
This publication has 36 references indexed in Scilit:
- Non-competitive androgen receptor inhibition in vitro and in vivoProceedings of the National Academy of Sciences, 2009
- A Common Motif Targets Huntingtin and the Androgen Receptor to the ProteasomeJournal of Biological Chemistry, 2008
- Targeting the androgen receptor pathway in prostate cancerCurrent Opinion in Pharmacology, 2008
- Gambogic Acid Inhibits Angiogenesis and Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2 SignalingCancer Research, 2008
- A surface on the androgen receptor that allosterically regulates coactivator bindingProceedings of the National Academy of Sciences, 2007
- Murine Cell Lines Derived from Pten Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer DevelopmentCancer Research, 2007
- Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-κB in HeLa cellsChemico-Biological Interactions, 2006
- Hsp90 as a therapeutic target in prostate cancerSeminars in Oncology, 2003
- Two Androgen Response Regions Cooperate in Steroid Hormone Regulated Activity of the Prostate-specific Antigen PromoterJournal of Biological Chemistry, 1996
- Ketoconazole Binds to the Human Androgen ReceptorHormone and Metabolic Research, 1992